TherapeuticsMD (TXMD) Other Accumulated Expenses (2010 - 2025)

TherapeuticsMD has reported Other Accumulated Expenses for 16 years, with the latest figure at $301000.0 in Q3 2025.

• For the quarter ending Q3 2025, Other Accumulated Expenses changed N/A year-over-year to $301000.0; the trailing twelve-month figure through Sep 2025 stood at $301000.0 (changed N/A YoY), and the FY2024 full-year result was $88000.0, down 78.48% from the prior year.
• Other Accumulated Expenses for Q3 2025 stood at $301000.0, up from $202000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $59.2 million in Q2 2022, with the low at $88000.0 in Q4 2024.
• Historically, Other Accumulated Expenses has averaged $16.2 million across 5 years, with a median of $11.5 million in 2023.
• Annual changes were most pronounced in 2021 — Other Accumulated Expenses surged 580.86% — and 2023, when it sank 97.83%.
• TherapeuticsMD's Other Accumulated Expenses stood at $13.3 million in 2021, then jumped by 41.3% to $18.8 million in 2022, then slumped by 97.83% to $409000.0 in 2023, then slumped by 78.48% to $88000.0 in 2024, then jumped by 242.05% to $301000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $301000.0 (Q3 2025), $202000.0 (Q2 2025), and $249000.0 (Q1 2025), per Business Quant data.